HYPERTRIGLYCERIDEMIA

This study is testing whether an oral medication called MN-001 can reduce liver fat and lower triglyceride levels in people who have non-alcoholic fatty liver disease, type 2 diabetes, and high triglycerides. About 40 participants will take either the study drug or a placebo pill…

This study is testing whether a new injectable drug called DR10624 can reduce the buildup of fatty plaque in the neck arteries of people who also have high blood triglycerides. About 40 participants will receive either the real drug or a placebo (dummy injection) weekly for 24 we…

This study is testing whether an experimental drug called MAR001 can safely lower high levels of triglycerides and remnant cholesterol in the blood. It involves 216 adults with elevated lipids who will receive either the drug or a placebo for comparison. The goal is to see if thi…

This early-stage study is testing a new drug called RN0361 to see if it is safe and can lower very high levels of triglycerides (a type of fat) in the blood. It will involve about 108 healthy adults and adults with high triglycerides. The main goals are to check for side effects …

This is the first study in humans to test the safety of an experimental drug called Kylo-12, which aims to lower high triglyceride levels in the blood. About 50 healthy volunteers with elevated triglycerides will receive either the drug or a placebo to check for side effects and …

This large, late-stage study is testing whether a new injectable drug called plozasiran can safely and effectively lower high triglyceride levels in the blood. About 1,456 adults with this condition will receive either the drug or a placebo shot every three months for a year. The…